Overview
Registration
Agenda
Faculty
View Archive

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Agios Pharmaceuticals, Inc.; Astex Pharmaceuticals, Inc.; Bristol Myers Squibb; Gilead Sciences, Inc.; Novartis Pharmaceuticals Corporation; Taiho Oncology, Inc.; and Takeda Oncology.

Improving Outcomes in MDS and MPN: Tailoring Treatment Based on Patient- and Disease-Specific Factors

Improving Outcomes in MDS and MPN: Tailoring Treatment Based on Patient- and Disease-Specific Factors


Friday, December 4, 2020

Live, Interactive Virtual Webcast!

7:00 PM – 9:30 PM PST

Overview

Treatment options for patients with myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDS) have changed rapidly in recent years for patients across the spectrum of risk stratification. The identification of gene markers including JAK2 and CALR have led to significant advances in the diagnosis and treatment of MPNs, while an increasing understanding of molecular alterations in MDS has impacted optimal disease management as well.

This live, online satellite symposium is designed to provide physicians with the knowledge to best individualize care for their patients based upon disease characteristics and symptom burden. This includes analyses of recent clinical trial data to illuminate effective strategies to implement current and emerging treatment options for MDS and MPNs. Safety considerations including management of underlying and treatment-related anemia will also be addressed.

Benefits of Attending

  • Update your clinical approach through a discussion of the most up-to-date risk-scoring systems for MPNs in patients with varying risk levels
  • Review best practices for management of patients with MDS and MPNs
  • Evaluate patients with MDS and MPNs for referral to appropriate clinical trials
  • Hear top experts develop treatment plans for patients with MDS and MPNs

Acknowledgment of Commercial Support

This activity is supported by educational grants from Agios Pharmaceuticals, Inc.; Astex Pharmaceuticals, Inc.; Bristol Myers Squibb; Gilead Sciences, Inc.; Novartis Pharmaceuticals Corporation; Taiho Oncology, Inc.; and Takeda Oncology.

Target Audience

These activities are intended for hematologists and hematologist/oncologists interested in the treatment of patients with MDS and MPNs.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate safety and efficacy data regarding emerging treatment options and novel formulations in the management of MDS and MPNs.
  • Develop an individualized plan of care based on risk stratification and symptom burden for patients with MDS and MPNs.
  • Outline mechanisms of anemia in MDS and MPNs, and novel strategies to treat underlying anemia.
  • Integrate emerging data into clinical scenarios to optimize care for patients with MDS and MPNs.

Program Chair

Guillermo Garcia-Manero, MD
Guillermo Garcia-Manero, MD
Professor
Chief, Section of Myelodysplastic Syndromes
Deputy Chair, Translational Research
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

Meeting information is accurate at the time of posting.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By